DTx Pharma Completes $100M Series B Financing to Advance its FALCON™ Platform and Pipeline of RNA Therapeutics

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2Pg8Htg
via IFTTT